Skip to main content
SpringerLink
Log in

Rotavirus vaccine: Current status

  • Annotations
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kapikian AZ, Wyatt RG, Greenberg HB et al. Approaches to immunization of infants and young children against gastroenteritis due to rotaviruses.Rev Infect Dis 1980;2: 459–69

    PubMed  CAS  Google Scholar 

  2. Delem A, Lobmann M, Zygraich N: A bovine rotavirus developed as a candidate vaccine for use in humans.J Biol Stand 1984;12: 443–5

    Article  PubMed  CAS  Google Scholar 

  3. Vesikari T, Isolauri E, d'Hondt E, Delem A, André FE, Zissis G. Protection of infants against rotavirus diarrhea by RIT 4237 attenuated bovine rotavirus strain vaccine.Lancet 1984;1: 977–81

    Article  PubMed  CAS  Google Scholar 

  4. Vesikari T, Isolauri E, Delem A, d'Hondt E, André FE, Beards GM, Flewett TH. Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic.J Pediatr 1985;107: 189–94

    Article  PubMed  CAS  Google Scholar 

  5. Bachmann P, Bishop RF, Flewett TJ, Kapikian AZ, Mathan MM, Zissis G. Nomenclature of human rotaviruses: designation of subgroups and serotypes.Bull WHO 1984;62: 501–3

    Google Scholar 

  6. Vesikari T, Müki M, Sarkkinen HK, Arstila P, Halonen PE. Rotavirus, adenovirus and non-viral enteropathogens in diarrhoea.Arch Dis Child 1981;56: 264–70

    Article  PubMed  CAS  Google Scholar 

  7. Vesikari T, Isolauri E, André FE. Protection of children for two years against rotavirus diarrhea by RIT 4237 bovine (NCDV) rotavirus vaccine. In: Holmgren J et al eds.Development of vaccines and drugs against diarrhea. 11th Nobel Conference, Stockholm 1985. Studenlitteratur, Lund: Sweden, 185–91

  8. DeMol P, Zissis G, Butzler J-P, Mutwewindago A, André FE. Failure of live, attenuated oral rotavirus vaccine.Lancet 1986;ii: 108

    Article  Google Scholar 

  9. John TJ. Antibody response of infants in tropics to five doses of oral poliovaccine.Br Med J 1976;1: 812

    PubMed  CAS  Google Scholar 

  10. Kapikian AZ, Midthun K, Hoshino Y et al. Rhesus rotavirus: a candidate vaccine for prevention of human rotavirus disease. In: Lerner RA et al eds.Vaccines 85: molecular and chemical basis of resistance to viral, bacterial and parasitic diseases. New York: Cold Spring Harbor Laboratory, 1985: 357–67

    Google Scholar 

  11. Vesikari T, Kapikian, AZ, Delem A, Zissis G. A comparative trial of rhesus monkey (RRV-1) and bovine (RIT 4237) oral rotavirus vaccines in young children.J Infect Dis 1986; 153: 832–9

    PubMed  CAS  Google Scholar 

  12. Kapikian AZ, Hoshino Y, Flores J et al. Alternative approaches to the development of a rotavirus vaccine. In: Holmgren J et al eds.Development of vaccines and drugs against diarrhea. 11th Nobel Conference, Stockholm 1985. Studentlitteratur, Lund: Sweden, 192–214

  13. Zissis G, Lambert JP, Marbehant P et al. Protection studies in colostrum-deprived piglets of a bovine rotavirus vaccine candidate using human rotavirus strains for challenge.J Infect Dis 1983;148: 1061–8.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Sciences, University of Tampere, SF-33520, Tampere, Finland

    Timo Vesikari

Authors
  1. Timo Vesikari
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vesikari, T. Rotavirus vaccine: Current status. Indian J Pediatr 54, 1–4 (1987). https://doi.org/10.1007/BF02751224

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02751224

Keywords

Search

Navigation